07.01.2015 • Topics

Europe’s dedicated chemical supply chain and logistics event

Europe’s dedicated chemical supply chain and logistics event

In its 14th year, LogiChem 2015 will open its gates between April 21st and 23rd in Antwerp (Belgium), addressing supply chain heads of chemicals manufacturers. With a new advisory board and more interactive formats including breakout workshops, case study revolutions, panel debates and customer insight forums, the conference will analyze the biggest decisions facing the heads of supply chain at Europe's top manufacturers, in light of the financial and competitive advantage they can deliver. The event's goal is to enable attendees to find the solutions and opportunities to combat these challenges and to support them as a leader in the chemical supply chain community. How?

  • Learning how to optimize transportation strategies to deliver maximum business benefit and navigate increasing complexities to reach the optimal logistics network design.
  • Listening to case studies from the top industry leaders on how to enhance business excellence through continuous improvement, leveraging supply chain sustainability to identify new efficiency savings opportunities. 
  • Hearing from innovative thought leaders on how to collaborate more effectively with suppliers to deliver additional value and innovation whilst minimizing costs. 
  • Learning how to connect the entire customer orientated value chain by integrating supply chain to drive value through the business.

CHEManager readers will receive a 20% discount off current prices - please use the code CHEMANAGER20 on the event's registration page.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read